Corrections & Clarifications

Corrections and clarifications — July 14, 2021

A Business page story titled “Rubicon buys Cipla arm’s oral liquid, nasal product unit” (July 10, 2021) erroneously described Rubicon as a specialty pharmaceutical company backed by General Electric. It should have been General Atlantic.


Our code of editorial values

This article is closed for comments.
Please Email the Editor

Printable version | Sep 26, 2021 8:08:20 AM | https://www.thehindu.com/opinion/Readers-Editor/corrections-and-clarifications/corrections-and-clarifications-july-14-2021/article35311077.ece

Next Story